Advisor Group Holdings, Inc. Innate Pharma Sa Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.0 - $3.55 $2,000 - $3,550	-1,000 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$2.7 - $4.8 $2,700 - $4,800	-1,000 Reduced 50.0%	1,000 $3,000
Q3 2021 Nov 05, 2021	BUY	$3.04 - $8.1 $3,040 - $8,100	1,000 Added 100.0%	2,000 $12,000
Q2 2021 Aug 02, 2021	SELL	$3.29 - $4.61 $3,290 - $4,610	-1,000 Reduced 50.0%	1,000 $3,000
Q1 2021 May 13, 2021	BUY	$4.09 - $4.83 $8,180 - $9,660	2,000 New	2,000 $9,000
Q4 2020 Feb 10, 2021	SELL	$3.85 - $5.62 $7,700 - $11,240	-2,000 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$3.8 - $7.95 $7,600 - $15,900	2,000 New	2,000 $13,000

238K

Ticker IPHA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,893,000
Market Cap $168M
Description
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.